Clinical Trial Update: Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 dose-finding clinical trial evaluating a whole-cell pneumococcal vaccine adjuvanted with alum (PATH-wSP) in healthy Kenyan adults and toddlers; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Pneumonia
• Pneumonia

Drugs mentioned

• PATH-wSP (sp Pneumoniae whole cell vaccine adsorbed to alum)

Snippet

Sponsor: PATH | Conditions: Pneumonia, Pneumococcal | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-06-12